Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism

被引:95
作者
Doorenbos, Carolina R. C. [1 ]
van den Born, Jacob [1 ]
Navis, Gerjan [1 ]
de Borst, Martin H. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, NL-9700 RB Groningen, Netherlands
关键词
CHRONIC KIDNEY-DISEASE; NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; NEPHRIN GENE-EXPRESSION; SMOOTH-MUSCLE-CELLS; 1,25-DIHYDROXYVITAMIN D-3; D SUPPLEMENTATION; D-RECEPTOR; D DEFICIENCY; 25-HYDROXYVITAMIN-D LEVELS;
D O I
10.1038/nrneph.2009.185
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Vitamin D is typically viewed as a key player in the regulation of calcium and phosphate levels and the control of bone metabolism; however, growing evidence suggests that vitamin D deficiency may also have an important role in the progressive loss of renal function. Vitamin D deficiency is particularly frequent in patients with chronic kidney disease, in whom it is associated with increased mortality. Studies indicate that treatment with vitamin D analogues reduces proteinuria, suppresses the renin-angiotensin-aldosterone system (RAAS), and exerts anti-inflammatory and immunomodulatory effects. These pleiotropic effects render vitamin D a potentially interesting treatment modality for renoprotection in patients with chronic kidney disease. Whether vitamin D has clinically relevant renoprotective effects in addition to RAAS blockade is currently under investigation.
引用
收藏
页码:691 / 700
页数:10
相关论文
共 116 条
[1]   Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity [J].
Adams, John S. ;
Hewison, Martin .
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (02) :80-90
[2]   Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists [J].
Adorini, Luciano ;
Penna, Giuseppe .
HUMAN IMMUNOLOGY, 2009, 70 (05) :345-352
[3]   Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation [J].
Andress, DL .
KIDNEY INTERNATIONAL, 2006, 69 (01) :33-43
[4]  
[Anonymous], KIDNEY DIS OUTCOMES
[5]  
[Anonymous], 2006, PRIMER METABOLIC BON
[6]   Vitamin D supplementation and total mortality - A meta-analysis of randomized controlled trials [J].
Autier, Philippe ;
Gandini, Sara .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (16) :1730-1737
[7]   Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis [J].
Avenell, Alison ;
Gillespie, William J. ;
Gillespie, Lesley D. ;
O'Connell, Dianne .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (02)
[8]   Vitamin D Affects Survival Independently of Vascular Calcification in Chronic Kidney Disease [J].
Barreto, Daniela Veit ;
Barreto, Fellype Carvalho ;
Liabeuf, Sophie ;
Temmar, Mohammed ;
Boitte, Francis ;
Choukroun, Gabriel ;
Fournier, Albert ;
Massy, Ziad A. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (06) :1128-1135
[9]   Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells [J].
Batenburg, Wendy W. ;
de Bruin, Rene J. A. ;
van Gool, Jeanette M. G. ;
Mueller, Dominik N. ;
Bader, Michael ;
Nguyen, Genevieve ;
Danser, A. H. Jan .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) :1151-1157
[10]   Assay variation confounds the diagnosis of hypovitaminosis D: A call for standardization [J].
Binkley, N ;
Krueger, D ;
Cowgill, CS ;
Plum, L ;
Lake, E ;
Hansen, KE ;
DeLuca, HF ;
Drezner, MK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07) :3152-3157